[
    "{\"step_by_step_thinking\": \"First, I need to find information about DNX-2401 in the provided documents. Document [1] mentions that DNX-2401 is an oncolytic adenovirus that has been evaluated in clinical trials for adults with recurrent glioblastoma and has shown promising results. The document also mentions that a clinical Phase I trial has been designed for newly diagnosed pediatric DIPG to investigate the feasibility, safety, and preliminary efficacy of delivering DNX-2401 into tumors. This indicates that DNX-2401 has been tested for the treatment of Diffuse Intrinsic Pontine Glioma.\", \"answer_choice\": \"A\"}"
]